Signaling by the phosphoinositide 3-kinase family in immune cells.

Phosphoinositide 3-kinases (PI3Ks) control many important aspects of immune cell development, differentiation, and function. Mammals have eight PI3K catalytic subunits that are divided into three classes based on similarities in structure and function. Specific roles for the class I PI3Ks have been broadly investigated and are relatively well understood, as is the function of their corresponding phosphatases. More recently, specific roles for the class II and class III PI3Ks have emerged. Through vertebrate evolution and in parallel with the evolution of adaptive immunity, there has been a dramatic increase not only in the genes for PI3K subunits but also in genes for phosphatases that act on 3-phosphoinositides and in 3-phosphoinositide-binding proteins. Our understanding of the PI3Ks in immunity is guided by fundamental discoveries made in simpler model organisms as well as by appreciating new adaptations of this signaling module in mammals in general and in immune cells in particular.

[1]  David K. Finlay,et al.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells , 2012, The Journal of experimental medicine.

[2]  Roger L. Williams,et al.  G Protein–Coupled Receptor–Mediated Activation of p110β by Gβγ Is Required for Cellular Transformation and Invasiveness , 2012, Science Signaling.

[3]  K. Okkenhaug,et al.  The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases , 2012, The open rheumatology journal.

[4]  M. Gold,et al.  Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies , 2012, Front. Immun..

[5]  A. Ferrando,et al.  HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes. , 2012, Blood.

[6]  A. Marshall,et al.  The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions , 2012, Front. Immun..

[7]  L. R. Perumalsamy,et al.  Distinct Spatial and Molecular Features of Notch Pathway Assembly in Regulatory T Cells , 2012, Science Signaling.

[8]  S. Feske,et al.  Ion channels , 2013, Thorax.

[9]  Dalya R. Soond,et al.  Pten Loss in CD4 T Cells Enhances Their Helper Function but Does Not Lead to Autoimmunity or Lymphoma , 2012, The Journal of Immunology.

[10]  L. Turka,et al.  Regulation of T Cell Homeostasis and Responses by Pten , 2012, Front. Immun..

[11]  S. Ward,et al.  Pharmacological Targeting of Phosphoinositide Lipid Kinases and Phosphatases in the Immune System: Success, Disappointment, and New Opportunities , 2012, Front. Immun..

[12]  M. Shlomchik,et al.  B Cell Receptor Signal Transduction in the GC Is Short-Circuited by High Phosphatase Activity , 2012, Science.

[13]  A. Bolino,et al.  Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. , 2012, Trends in molecular medicine.

[14]  Dalya R. Soond,et al.  Does the PI3K pathway promote or antagonize regulatory T cell development and function? , 2012, Front. Immun..

[15]  D. Fruman,et al.  Akt and mTOR in B Cell Activation and Differentiation , 2012, Front. Immun..

[16]  R. Flavell,et al.  Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasis , 2012, Proceedings of the National Academy of Sciences.

[17]  M. Falasca,et al.  Regulation and cellular functions of class II phosphoinositide 3-kinases. , 2012, The Biochemical journal.

[18]  A. Hirao,et al.  PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ. , 2021, Cell reports.

[19]  A. Ferrando,et al.  Targeting nonclassical oncogenes for therapy in T-ALL. , 2012, Cancer cell.

[20]  A. Marshall,et al.  p110δ Phosphoinositide 3-Kinase Represses IgE Switch by Potentiating BCL6 Expression , 2012, The Journal of Immunology.

[21]  Guoxing Wang,et al.  Receptor Signaling Lymphocyte-activation Molecule Family 1 (Slamf1) Regulates Membrane Fusion and NADPH Oxidase 2 (NOX2) Activity by Recruiting a Beclin-1/Vps34/Ultraviolet Radiation Resistance-associated Gene (UVRAG) Complex* , 2012, The Journal of Biological Chemistry.

[22]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[23]  D. Hodson,et al.  Regulation of lymphocyte development and function by RNA-binding proteins. , 2012, Current opinion in immunology.

[24]  M. Horton,et al.  Regulation of immune responses by mTOR. , 2012, Annual review of immunology.

[25]  Qingsheng Li,et al.  Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. , 2012, Immunity.

[26]  D. Fruman,et al.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. , 2012, The Biochemical journal.

[27]  Markus Werner,et al.  FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination , 2012, The Journal of experimental medicine.

[28]  N. Ktistakis,et al.  How phosphoinositide 3-phosphate controls growth downstream of amino acids and autophagy downstream of amino acid withdrawal. , 2012, Biochemical Society transactions.

[29]  W. Zong,et al.  Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function , 2012, Proceedings of the National Academy of Sciences.

[30]  Ian Mcleod,et al.  Macroautophagy in T Lymphocyte Development and Function , 2011, Front. Immun..

[31]  C. Rommel,et al.  PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic. , 2011, Cancer discovery.

[32]  Ian Mcleod,et al.  The Class III Kinase Vps34 Promotes T Lymphocyte Survival through Regulating IL-7Rα Surface Expression , 2011, The Journal of Immunology.

[33]  John E. Burke,et al.  Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases , 2011, Science Signaling.

[34]  G. Semenza,et al.  Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.

[35]  A. Iwasaki,et al.  Autophagy in the control and pathogenesis of viral infection. , 2011, Current opinion in virology.

[36]  Roger L. Williams,et al.  Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α , 2011, Structure.

[37]  E. Hirsch,et al.  The RacGAP ArhGAP15 is a master negative regulator of neutrophil functions. , 2011, Blood.

[38]  T. Ludwig,et al.  The GTPase-activating protein ARAP3 regulates chemotaxis and adhesion-dependent processes in neutrophils. , 2011, Blood.

[39]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[40]  S. Gygi,et al.  Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling , 2011, Science.

[41]  S. McColl,et al.  PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. , 2011, Journal of autoimmunity.

[42]  A. Toker,et al.  Akt isoform-specific signaling in breast cancer , 2011, Cell adhesion & migration.

[43]  Qingsheng Li,et al.  A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. , 2011, Immunity.

[44]  K. Okkenhaug,et al.  PI3Kβ Plays a Critical Role in Neutrophil Activation by Immune Complexes , 2011, Science Signaling.

[45]  D. Sabatini,et al.  The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling , 2011, Science.

[46]  Roger L. Williams,et al.  Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism , 2011, Molecular cell.

[47]  Julian Downward,et al.  RAS Interaction with PI3K: More Than Just Another Effector Pathway. , 2011, Genes & cancer.

[48]  David K. Finlay,et al.  Protein Kinase B Controls Transcriptional Programs that Direct Cytotoxic T Cell Fate but Is Dispensable for T Cell Metabolism , 2011, Immunity.

[49]  D. Rappolee,et al.  The Phosphoinositide Kinase PIKfyve Is Vital in Early Embryonic Development , 2011, The Journal of Biological Chemistry.

[50]  David K. Finlay,et al.  Metabolism, migration and memory in cytotoxic T cells , 2011, Nature Reviews Immunology.

[51]  K. Anderson,et al.  P-Rex1 and Vav1 Cooperate in the Regulation of Formyl-Methionyl-Leucyl-Phenylalanine–Dependent Neutrophil Responses , 2011, The Journal of Immunology.

[52]  Xiaoping Zhou,et al.  The Mammalian Class 3 PI3K (PIK3C3) Is Required for Early Embryogenesis and Cell Proliferation , 2011, PloS one.

[53]  H. Virgin,et al.  Autophagy in immunity and inflammation , 2011, Nature.

[54]  R. Ulrich,et al.  CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. , 2011, Blood.

[55]  Y. Ohsumi,et al.  PtdIns 3-Kinase Orchestrates Autophagosome Formation in Yeast , 2011, Journal of lipids.

[56]  W. Kerr.  Inhibitor and activator: dual functions for SHIP in immunity and cancer , 2011, Annals of the New York Academy of Sciences.

[57]  P. Hawkins,et al.  PtdIns3P and Rac direct the assembly of the NADPH oxidase on a novel, pre-phagosomal compartment during FcR-mediated phagocytosis in primary mouse neutrophils. , 2010, Blood.

[58]  G. Giles,et al.  Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers , 2010, Proceedings of the National Academy of Sciences.

[59]  D. Powell,et al.  Requirement for Class II Phosphoinositide 3-Kinase C2α in Maintenance of Glomerular Structure and Function , 2010, Molecular and Cellular Biology.

[60]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[61]  Dalya R. Soond,et al.  Phosphoinositide 3-Kinase Activity in T Cells Regulates the Magnitude of the Germinal Center Reaction , 2010, The Journal of Immunology.

[62]  M. Boes,et al.  SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages , 2010, Nature Immunology.

[63]  M. Janas,et al.  Stromal cell-derived factor 1α and CXCR4: newly defined requirements for efficient thymic β-selection. , 2010, Trends in immunology.

[64]  Melissa C. Hendershott,et al.  mRNA Degradation Plays a Significant Role in the Program of Gene Expression Regulated by Phosphatidylinositol 3-Kinase Signaling , 2010, Molecular and Cellular Biology.

[65]  Markus Werner,et al.  Role of PI3K in the generation and survival of B cells , 2010, Immunological reviews.

[66]  P. Vogt,et al.  Cancer-derived mutations in the regulatory subunit p85α of phosphoinositide 3-kinase function through the catalytic subunit p110α , 2010, Proceedings of the National Academy of Sciences.

[67]  K. Okkenhaug,et al.  The PI3K Isoforms p110α and p110δ Are Essential for Pre–B Cell Receptor Signaling and B Cell Development , 2010, Science Signaling.

[68]  A. Kiger,et al.  Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions , 2010, The Journal of cell biology.

[69]  M. Merkenschlager,et al.  PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors , 2010, The Journal of experimental medicine.

[70]  R. DePinho,et al.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells , 2010, Nature Immunology.

[71]  B. Vanhaesebroeck,et al.  Activity of any class IA PI3K isoform can sustain cell proliferation and survival , 2010, Proceedings of the National Academy of Sciences.

[72]  G. Hortobagyi,et al.  Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer. , 2010, Cancer research.

[73]  M. Birnbaum,et al.  AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. , 2010, Blood.

[74]  M. Birnbaum,et al.  Akt1 and Akt2 promote peripheral B-cell maturation and survival. , 2010, Blood.

[75]  D. Rigden,et al.  Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation , 2010, Autophagy.

[76]  B. Vanhaesebroeck,et al.  The emerging mechanisms of isoform-specific PI3K signalling , 2010, Nature Reviews Molecular Cell Biology.

[77]  R. Teasdale,et al.  Inhibition of the PtdIns(5) kinase PIKfyve disrupts intracellular replication of Salmonella , 2010, The EMBO journal.

[78]  D. Sabatini,et al.  Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.

[79]  K. Shokat,et al.  Shaping Development of Autophagy Inhibitors with the Structure of the Lipid Kinase Vps34 , 2010, Science.

[80]  Dalya R. Soond,et al.  PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. , 2010, Blood.

[81]  S. Grinstein,et al.  In vivo requirement for Atg5 in antigen presentation by dendritic cells. , 2010, Immunity.

[82]  H. Guillou,et al.  ARAP3 binding to phosphatidylinositol-(3,4,5)-trisphosphate depends on N-terminal tandem PH domains and adjacent sequences. , 2010, Cellular signalling.

[83]  Qingsheng Li,et al.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. , 2010, Immunity.

[84]  M. Turner,et al.  Thymic development beyond β-selection requires phosphatidylinositol 3-kinase activation by CXCR4 , 2010, The Journal of experimental medicine.

[85]  Yi Liu,et al.  The p110δ crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors , 2009, Nature chemical biology.

[86]  S. Smerdon,et al.  Function of the Nucleotide Exchange Activity of Vav1 in T Cell Development and Activation , 2009, Science Signaling.

[87]  T. Mak,et al.  Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase , 2009, Proceedings of the National Academy of Sciences.

[88]  M. Girvin,et al.  Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110α and are disrupted in oncogenic p85 mutants , 2009, Proceedings of the National Academy of Sciences.

[89]  R. Rickert,et al.  Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. , 2009, Immunity.

[90]  M. Gold,et al.  Phosphoinositide 3-Kinase p110δ Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses1 , 2009, The Journal of Immunology.

[91]  R. DePinho,et al.  PI3 Kinase Signals BCR-Dependent Mature B Cell Survival , 2009, Cell.

[92]  David K. Finlay,et al.  Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes , 2009, The Journal of experimental medicine.

[93]  Michael Loran Dustin,et al.  The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells. , 2009, Molecular biology of the cell.

[94]  S. Hedrick.  The cunning little vixen: Foxo and the cycle of life and death , 2009, Nature Immunology.

[95]  P. Pandolfi,et al.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. , 2009, Cancer cell.

[96]  K. Okkenhaug,et al.  The p110δ Isoform of Phosphatidylinositol 3-Kinase Controls Susceptibility to Leishmania major by Regulating Expansion and Tissue Homing of Regulatory T Cells1 , 2009, The Journal of Immunology.

[97]  B. Cubelos,et al.  Essential function for the GTPase TC21 in homeostatic antigen receptor signaling , 2009, Nature Immunology.

[98]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[99]  Daniel R. Beisner,et al.  Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. , 2009, Nature immunology.

[100]  K. Okkenhaug,et al.  p110γ and p110δ isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease , 2009, Proceedings of the National Academy of Sciences.

[101]  R. Gascoyne,et al.  Selective ablation of the YxxM motif of IL-7Rα suppresses lymphomagenesis but maintains lymphocyte development , 2009, Oncogene.

[102]  R. Michell,et al.  Phosphatidylinositol 3,5-bisphosphate and Fab1p/PIKfyve underPPIn endo-lysosome function. , 2009, The Biochemical journal.

[103]  R. Flavell,et al.  An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. , 2009, Immunity.

[104]  D. Fruman,et al.  Fine tuning the immune response with PI3K , 2009, Immunological reviews.

[105]  M. Reth,et al.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling , 2009, Nature Reviews Immunology.

[106]  Daniel R. Beisner,et al.  Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor , 2009, Nature Immunology.

[107]  Y. Terauchi,et al.  Critical role of class IA PI3K for c-Rel expression in B lymphocytes. , 2009, Blood.

[108]  P. Hawkins,et al.  CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks. , 2008, Blood.

[109]  K. Shokat,et al.  Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. , 2008, The Journal of allergy and clinical immunology.

[110]  R. DePinho,et al.  Distinct roles for Foxo1 at multiple stages of B cell differentiation , 2008, Nature Immunology.

[111]  P. Musiani,et al.  Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development , 2008, Science Signaling.

[112]  Jason S. Mitchell,et al.  The p110γ isoform of phosphatidylinositol 3‐kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites , 2008, Journal of leukocyte biology.

[113]  V. Lazar,et al.  FOXO1 Regulates L-Selectin and a Network of Human T Cell Homing Molecules Downstream of Phosphatidylinositol 3-Kinase1 , 2008, The Journal of Immunology.

[114]  Gareth Griffiths,et al.  Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum , 2008, The Journal of cell biology.

[115]  M. Loda,et al.  Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis , 2008, Nature.

[116]  K. Okkenhaug,et al.  The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ , 2008, Proceedings of the National Academy of Sciences.

[117]  David M. Sabatini,et al.  The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.

[118]  David K. Finlay,et al.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR , 2008, Proceedings of the National Academy of Sciences.

[119]  M. Schlissel,et al.  Foxo1 directly regulates the transcription of recombination-activating genes during B cell development , 2008, Nature Immunology.

[120]  R. DePinho,et al.  SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway , 2008, Nature Immunology.

[121]  K. Rittinger,et al.  Crucial structural role for the PH and C1 domains of the Vav1 exchange factor , 2008, EMBO reports.

[122]  Holger Gerhardt,et al.  Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration , 2008, Nature.

[123]  Tobias Meyer,et al.  Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. , 2008, Molecular cell.

[124]  Michael G. Kharas,et al.  KLF4 is a FOXO target gene that suppresses B cell proliferation. , 2008, International immunology.

[125]  M. Juntilla,et al.  Critical roles of the PI3K/Akt signaling pathway in T cell development. , 2008, Immunology letters.

[126]  R. Rickert,et al.  Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases , 2008, The Journal of experimental medicine.

[127]  Li Zhao,et al.  Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms , 2008, Proceedings of the National Academy of Sciences.

[128]  John L Cleveland,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.

[129]  J. Backer.  The regulation and function of Class III PI3Ks: novel roles for Vps34. , 2008, The Biochemical journal.

[130]  S. Jameson,et al.  Selective Regulation of CD8 Effector T Cell Migration by the p110γ Isoform of Phosphatidylinositol 3-Kinase1 , 2008, The Journal of Immunology.

[131]  K. Okkenhaug,et al.  CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. , 2008, Blood.

[132]  M. Lemmon,et al.  Membrane recognition by phospholipid-binding domains , 2008, Nature Reviews Molecular Cell Biology.

[133]  P. Pandolfi,et al.  The Effect of Deleting p110δ on the Phenotype and Function of PTEN-Deficient B Cells1 , 2008, The Journal of Immunology.

[134]  Bert Vogelstein,et al.  The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations , 2007, Science.

[135]  K. Okkenhaug,et al.  Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. , 2007, Blood.

[136]  P. Hawkins,et al.  PI3K Class IB Pathway , 2007, Science's STKE.

[137]  B. Hemmings,et al.  Deletion of PKBα/Akt1 Affects Thymic Development , 2007, PloS one.

[138]  G. Prestwich,et al.  Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase γ , 2007, Proceedings of the National Academy of Sciences.

[139]  M. Birnbaum,et al.  Akt1 and Akt2 are required for αβ thymocyte survival and differentiation , 2007, Proceedings of the National Academy of Sciences.

[140]  Yuval Inbar,et al.  Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit , 2007, Science.

[141]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[142]  David K. Finlay,et al.  Notch-induced T cell development requires phosphoinositide-dependent kinase 1 , 2007, The EMBO journal.

[143]  G. Stamp,et al.  Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.

[144]  D. Nemazee,et al.  Basal B Cell Receptor-Directed Phosphatidylinositol 3-Kinase Signaling Turns Off RAGs and Promotes B Cell-Positive Selection1 , 2007, The Journal of Immunology.

[145]  B. Vanhaesebroeck,et al.  Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers , 2007, Proceedings of the National Academy of Sciences.

[146]  T. Ludwig,et al.  Unequal Contribution of Akt Isoforms in the Double-Negative to Double-Positive Thymocyte Transition1 , 2007, The Journal of Immunology.

[147]  Michael G. Kharas,et al.  T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. , 2007, Blood.

[148]  A. Iwasaki,et al.  In Brief , 2007, Nature Reviews Immunology.

[149]  C. Rommel,et al.  PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond? , 2007, Nature Reviews Immunology.

[150]  M. Turner,et al.  Cutting Edge: The PI3K p110δ Is Required for Down-Regulation of RAG Expression in Immature B Cells1 , 2007, The Journal of Immunology.

[151]  K. Okkenhaug,et al.  Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K , 2007, Trends in immunology.

[152]  K. Okkenhaug,et al.  Role of the phosphoinositide 3‐kinase p110δ in generation of type 2 cytokine responses and allergic airway inflammation , 2007, European journal of immunology.

[153]  S. Armstrong,et al.  FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.

[154]  K. Okkenhaug,et al.  Cutting Edge: The Phosphoinositide 3-Kinase p110δ Is Critical for the Function of CD4+CD25+Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[155]  Hailing Cheng,et al.  The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation , 2006, Proceedings of the National Academy of Sciences.

[156]  K. Okkenhaug,et al.  The p110δ Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells1 , 2006, The Journal of Immunology.

[157]  P. Hawkins,et al.  PtdIns3P binding to the PX domain of p40phox is a physiological signal in NADPH oxidase activation , 2006, The EMBO journal.

[158]  L. Turka,et al.  Cutting Edge: T Cell Requirement for CD28 Costimulation Is Due to Negative Regulation of TCR Signals by PTEN1 , 2006, The Journal of Immunology.

[159]  K. Calame,et al.  Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. , 2006, Immunity.

[160]  P. Hawkins,et al.  Signalling through Class I PI3Ks in mammalian cells. , 2006, Biochemical Society transactions.

[161]  J. Dixon,et al.  Myotubularin phosphatases: policing 3-phosphoinositides. , 2006, Trends in cell biology.

[162]  E. Skolnik,et al.  Phosphatidylinositol-3 Phosphatase Myotubularin-Related Protein 6 Negatively Regulates CD4 T Cells , 2006, Molecular and Cellular Biology.

[163]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[164]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[165]  Xi C. He,et al.  PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.

[166]  S. Morrison,et al.  Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.

[167]  Robbie Loewith,et al.  A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling , 2006, Cell.

[168]  K. Okkenhaug,et al.  Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation , 2006, Nature.

[169]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[170]  W. Swat,et al.  Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. , 2006, Blood.

[171]  B. Vanhaesebroeck,et al.  Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[172]  K. Okkenhaug,et al.  Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. , 2006, Blood.

[173]  D. F. Barber,et al.  Class IB-Phosphatidylinositol 3-Kinase (PI3K) Deficiency Ameliorates IA-PI3K-Induced Systemic Lupus but Not T Cell Invasion1 , 2006, The Journal of Immunology.

[174]  P. Khavari,et al.  The Class II Phosphoinositide 3-Kinase C2β Is Not Essential for Epidermal Differentiation , 2005, Molecular and Cellular Biology.

[175]  E. Skolnik,et al.  Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1. , 2005, Molecular biology of the cell.

[176]  F. Natt,et al.  Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[177]  S. Ruf,et al.  Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells. , 2005, Immunity.

[178]  M. Ciofani,et al.  Notch promotes survival of pre–T cells at the β-selection checkpoint by regulating cellular metabolism , 2005, Nature Immunology.

[179]  Emilio Hirsch,et al.  Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis , 2005, Nature Medicine.

[180]  E. Vigorito,et al.  Cutting Edge: T Cell Development Requires the Combined Activities of the p110γ and p110δ Catalytic Isoforms of Phosphatidylinositol 3-Kinase1 , 2005, The Journal of Immunology.

[181]  K. Okkenhaug,et al.  Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. , 2005, Blood.

[182]  E. Skolnik,et al.  The Phosphatidylinositol 3-Phosphate Phosphatase Myotubularin- Related Protein 6 (MTMR6) Is a Negative Regulator of the Ca2+-Activated K+ Channel KCa3.1 , 2005, Molecular and Cellular Biology.

[183]  Kong-Peng Lam,et al.  Basal Immunoglobulin Signaling Actively Maintains Developmental Stage in Immature B Cells , 2005, PLoS biology.

[184]  T. Tuschl,et al.  Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy , 2005, Science.

[185]  Thijs J. Hagenbeek,et al.  The Loss of PTEN Allows TCR αβ Lineage Thymocytes to Bypass IL-7 and Pre-TCR–mediated Signaling , 2004, The Journal of experimental medicine.

[186]  C. Martínez-A,et al.  Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. , 2004, Immunity.

[187]  K. Okkenhaug,et al.  Cutting Edge: Differential Roles for Phosphoinositide 3-Kinases, p110γ and p110δ, in Lymphocyte Chemotaxis and Homing1 , 2004, The Journal of Immunology.

[188]  Y. Samuels,et al.  Oncogenic mutations of PIK3CA in human cancers. , 2004, Current topics in microbiology and immunology.

[189]  N. Rajewsky,et al.  Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β Heterodimer , 2004, Cell.

[190]  F. McCormick,et al.  Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They Regulate , 2004, Molecular and Cellular Biology.

[191]  D. Alessi,et al.  The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development , 2004, Nature Immunology.

[192]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[193]  D. Fruman,et al.  Phosphoinositide 3-kinase: diverse roles in immune cell activation. , 2004, Annual review of immunology.

[194]  Oreste Acuto,et al.  CD28-mediated co-stimulation: a quantitative support for TCR signalling , 2003, Nature Reviews Immunology.

[195]  P. Hawkins,et al.  Phosphoinositide 3‐kinase‐dependent activation of Rac , 2003, FEBS letters.

[196]  S. Koyasu.  The role of PI3K in immune cells , 2003, Nature Immunology.

[197]  K. Okkenhaug,et al.  PI3K in lymphocyte development, differentiation and activation , 2003, Nature Reviews Immunology.

[198]  T. Mak,et al.  Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination , 2003, The Journal of experimental medicine.

[199]  D. Staunton,et al.  Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement , 2003, The Journal of Immunology.

[200]  T. Behrens,et al.  PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction , 2003, Nature Immunology.

[201]  J. Ihle,et al.  Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex , 2002, Molecular and Cellular Biology.

[202]  E. Vigorito,et al.  A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation , 2002, The Journal of experimental medicine.

[203]  T. Asano,et al.  PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.

[204]  K. Okkenhaug,et al.  Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.

[205]  P. Lipp,et al.  Phosphatidylinositol 3-phosphate is generated in phagosomal membranes , 2001, Current Biology.

[206]  S. Grinstein,et al.  Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation , 2001, The Journal of cell biology.

[207]  S. Emr,et al.  The role of phosphoinositides in membrane transport. , 2001, Current opinion in cell biology.

[208]  Paul Tempst,et al.  PtdIns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40phox , 2001, Nature Cell Biology.

[209]  M. Yaffe,et al.  The PX domains of p47phox and p40phox bind to lipid products of PI(3)K , 2001, Nature Cell Biology.

[210]  T. Sasaki,et al.  T cell-specific loss of Pten leads to defects in central and peripheral tolerance. , 2001, Immunity.

[211]  Takeshi Noda,et al.  Two Distinct Vps34 Phosphatidylinositol 3–Kinase Complexes Function in Autophagy and Carboxypeptidase Y Sorting inSaccharomyces cerevisiae , 2001, The Journal of cell biology.

[212]  M. Lemmon,et al.  Signal-dependent membrane targeting by pleckstrin homology (PH) domains. , 2000, The Biochemical journal.

[213]  W L Stanford,et al.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.

[214]  Dianqing Wu,et al.  Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .

[215]  Silvano Sozzani,et al.  Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .

[216]  Paul M. Allen,et al.  Proline Residues in Cd28 and the Src Homology (Sh)3 Domain of Lck Are Required for T Cell Costimulation , 1999, The Journal of experimental medicine.

[217]  Gillian E. Wu,et al.  Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. , 1998, Journal of immunology.

[218]  J. Backer,et al.  Regulation of the p85/p110alpha phosphatidylinositol 3'-kinase. Distinct roles for the n-terminal and c-terminal SH2 domains. , 1998, The Journal of biological chemistry.

[219]  Marino Zerial,et al.  EEA1 links PI(3)K function to Rab5 regulation of endosome fusion , 1998, Nature.

[220]  J. Backer,et al.  Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit , 1998, Molecular and Cellular Biology.

[221]  P. Hawkins,et al.  Phosphatidylinositol 3-kinase-γ activates Bruton’s tyrosine kinase in concert with Src family kinases , 1997 .

[222]  P. Parker,et al.  Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis , 1997, Nature.

[223]  K. Rajewsky,et al.  In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.

[224]  L. Cantley,et al.  A Comparative Analysis of the Phosphoinositide Binding Specificity of Pleckstrin Homology Domains* , 1997, The Journal of Biological Chemistry.

[225]  G. Panayotou,et al.  Phosphoinositide 3-kinases: a conserved family of signal transducers. , 1997, Trends in biochemical sciences.

[226]  M. Zvelebil,et al.  p110δ, a novel phosphoinositide 3-kinase in leukocytes , 1997 .

[227]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[228]  M. Owen,et al.  The interleukin‐7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. , 1996, The EMBO journal.

[229]  D. Tuveson,et al.  CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. , 1993, Science.

[230]  S. Emr,et al.  A membrane‐associated complex containing the Vps15 protein kinase and the Vps34 PI 3‐kinase is essential for protein sorting to the yeast lysosome‐like vacuole. , 1993, The EMBO journal.

[231]  K. Takegawa,et al.  Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. , 1993, Science.

[232]  I. Batty,et al.  Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases. , 2012, Advances in biological regulation.

[233]  B. Vogelstein,et al.  Structural effects of oncogenic PI3Kα mutations. , 2010, Current topics in microbiology and immunology.

[234]  D. Fruman.  Regulatory subunits of class IA PI3K. , 2010, Current topics in microbiology and immunology.

[235]  K. Okkenhaug,et al.  PI3Ks in lymphocyte signaling and development. , 2010, Current topics in microbiology and immunology.

[236]  K. Okkenhaug,et al.  This information is current as Signaling in CD 8 T Cells S 6 Phosphorylation to Control Metabolic Converge at the Level of Ribosomal Protein Mammalian Target of Rapamycin Pathways MAPK , Phosphatidylinositol 3-Kinase , and , 2009 .

[237]  P. Schwartzberg,et al.  Tec family kinases in T lymphocyte development and function. , 2005, Annual review of immunology.

[238]  P. Lipp,et al.  Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. , 2002, Molecular cell.